CAAP Company: SYNG Pharmaceuticals Chosen to Attend the Biocom Global Life Science Partnering Conference

Former OBIO CAAP company Syng Pharmaceuticals, will be attending the BIOCOM Global Pharma Partnering Conference this week.  The Consulate of Canada in San Diego with support from the Ministry of Innovation, Science and Economic Development and the federal Industrial Research Assistance Program, chose SYNG Pharma as one of ten Canadian companies to receive coaching and mentoring in advance of the 2017 BIOCOM Global Pharma Partnering Conference, March 1-2, 2017.

Click to Read the Release Here